Dancann Pharma aktie (DANCAN) | Pressmeddelande - Börskollen
Börskollen - Aktier, fonder och ekonominyheter

Börskollen

För dig med koll på börsen

•Rapportsäsong: Här är bolagen som rapporterar idag den 22 november

Pressmeddelanden från Dancann Pharma

 Bevaka pressreleaser
Kurs från TradingView
StartNyheterPressreleaserRiktkurserInsynshandelBlankningAnalyserBloggarVideosPodcasts

DanCann Pharma A/S: The Danish Government Proposes Permanent Scheme for Prescription-Based Medicinal Cannabis for Danish Patients

COPENHAGEN, Denmark, 19 November 2024 – DanCann Pharma A/S (SS: DANCAN) (“DanCann Pharma” or the “Company”), a Danish company powered by can...

Cision • 19 Nov 09:30

DanCann Pharma A/S: Capital reduction in DanCann Pharma A/S is completed

The capital reduction in DanCann Pharma A/S as resolved on an extraordinary general meeting held on 7 October 2024 has been completed today,...

Cision • 05 Nov 17:30

Minutes of extraordinary general meeting

held in DanCann Pharma A/S, CVR-no. 39 42 60 05 (“Company”)

Cision • 07 Oct 12:30

DanCann Pharma A/S: Calls for an Extraordinary General Meeting regarding New Authorizations and Reduction of Share Capital in Preparation for Reverse Stock Split

COPENHAGEN, Denmark, 24 September 2024 - DanCann Pharma A/S (SS: DANCAN) ("DanCann Pharma" or the "Company"), a Danish company powered by ca...

Cision • 24 Sep 16:00

NOTICE OF EXTRAORDINARY GENERAL MEETING IN DANCANN PHARMA A/S

NOTICE OF EXTRAORDINARY GENERAL MEETING IN DANCANN PHARMA A/S

Cision • 20 Sep 18:00

DanCann Pharma A/S: Number of Reported Suspected Adverse Reactions Drops by Two-Thirds in 2023 Despite 72% Growth in the Medicinal Cannabis Pilot Programme

COPENHAGEN, Denmark, 18 September 2024 - DanCann Pharma A/S (SS: DANCAN) ("DanCann Pharma" or the "Company"), a Danish company powered by ca...

Cision • 18 Sep 12:00

DanCann Pharma A/S: Quarterly CEO Reflection

COPENHAGEN, Denmark, 14 August 2024 - DanCann Pharma A/S (SS: DANCAN) ("DanCann Pharma" or the "Company"), a Danish company powered by canna...

Cision • 14 Aug 08:15

DanCann Pharma A/S Publishes Q2-2024 Report: Record Revenue and First-Ever Positive EBITDA

COPENHAGEN, Denmark, 14 August 2024 - DanCann Pharma A/S (SS: DANCAN) ("DanCann Pharma" or the "Company"), a Danish company powered by canna...

Cision • 14 Aug 08:00

DanCann Pharma A/S announces last day for trading in temporary shares

NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, HONG KONG, JAPAN, CANADA, RUS...

Cision • 03 Jul 08:00

DanCann Pharma A/S announces outcome of the Rights Issue

NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, HONG KONG, JAPAN, CANADA, RUS...

Cision • 27 Jun 18:45

DanCann Pharma A/S: Last day of subscription of shares in the ongoing Rights Issue is 20 June 2024 on Nordnet Bank and Avanza Bank

NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, WITHIN OR TO THE UNITED STATES, AUSTRALIA, CANADA,...

Cision • 19 Jun 12:00

DanCann Pharma A/S: Solid growth in the Rx portfolio

COPENHAGEN, Denmark, 18 June 2024 - DanCann Pharma A/S (SS: DANCAN) ("DanCann Pharma" or the "Company"), a Danish company powered by cannabi...

Cision • 18 Jun 13:00

DanCann Pharma A/S: Germany trends – prescriptions for medicinal cannabis positively influenced by new legalization

COPENHAGEN, Denmark, 14 June 2024 - DanCann Pharma A/S (SS: DANCAN) ("DanCann Pharma" or the "Company"), a Danish company powered by cannabi...

Cision • 14 Jun 09:00

DanCann Pharma A/S: Submits applications for FLS03 and FLS04 to expand portfolio

COPENHAGEN, Denmark, 12 June 2024 - DanCann Pharma A/S (SS: DANCAN) ("DanCann Pharma" or the "Company"), a Danish company powered by cannabi...

Cision • 12 Jun 09:00

DanCann Pharma A/S: The subscription period of DanCann Pharma’s Rights Issue begins today

NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, WITHIN OR TO THE UNITED STATES, AUSTRALIA, CANADA,...

Cision • 11 Jun 08:00

DanCann Pharma A/S: Publishes Q1-2024 Report

COPENHAGEN, Denmark, 01 June 2024 - DanCann Pharma A/S (SS: DANCAN) ("DanCann Pharma" or the "Company"), a Danish company powered by cannabi...

Cision • 01 Jun 19:30

DanCann Pharma A/S: Minutes OF ANNUAL GENERAL MEETING

held in DanCann Pharma A/S, CVR-no. 39 42 60 05 (“Company”)

Cision • 30 May 12:15

DanCann Pharma A/S: The Board of Directors has resolved on a partially (48.88 percent) secured Rights Issue of approximately DKK 18.33 million and publishes memorandum

COPENHAGEN, Denmark, 24 May 2024 – DanCann Pharma A/S (SS: DANCAN) ("DanCann Pharma" or the “Company”), a Danish company powered by cannabin...

Cision • 24 May 10:15

DanCann Pharma A/S: Capital reduction completed

The capital reduction in DanCann Pharma A/S as resolved on an extraordinary general meeting held on 17 April 2024 has been completed today, ...

Cision • 16 May 20:30

NOTICE OF ANNUAL GENERAL MEETING 2024 IN DANCANN PHARMA A/S

NOTICE OF ANNUAL GENERAL MEETING 2024 IN DANCANN PHARMA A/S

Cision • 15 May 22:15

DanCann Pharma A/S Publishes Its Annual Report for 2023: A Year of Strategic Review and Future Focus on Capital Efficiency and Profitability

COPENHAGEN, Denmark, 15 May 2024 - DanCann Pharma A/S (SS: DANCAN) ("DanCann Pharma" or the "Company"), a Danish company powered by cannabin...

Cision • 15 May 22:00

DanCann Pharma A/S: Updated time plan and material terms of the rights issue

COPENHAGEN, Denmark, 15 May 2024 - DanCann Pharma A/S (SS: DANCAN) ("DanCann Pharma" or the "Company"), a Danish company powered by cannabin...

Cision • 15 May 18:00

DanCann Pharma A/S: MINUTES OF EXTRAORDINARY GENERAL MEETING

held in DanCann Pharma A/S, CVR-no. 39 42 60 05 (“Company”)

Cision • 17 Apr 12:00

NOTICE OF EXTRAORDINARY GENERAL MEETING IN DANCANN PHARMA A/S

NOTICE OF EXTRAORDINARY GENERAL MEETING IN DANCANN PHARMA A/S

Cision • 02 Apr 22:30

Correction: DanCann Pharma A/S intends to initiate and complete a partly secured rights issue of up to DKK 18.5 million to restructure, strengthen and secure a debt-free capital structure

Correction to the press release issued yesterday: The previous press release incorrectly stated that underwriters had been secured for DKK 1...

Cision • 30 Mar 10:15

DanCann Pharma A/S intends to initiate and complete a partly secured rights issue of up to DKK 18.5 million to restructure, strengthen and secure a debt-free capital structure

COPENHAGEN, Denmark, 29 March 2024 – DanCann Pharma A/S (SS: DANCAN) ("DanCann Pharma" or the "Company"), a Danish company powered by cannab...

Cision • 29 Mar 13:00

DanCann Pharma A/S: Germany makes historic move towards cannabis reclassification and legalization

COPENHAGEN, Denmark, 28 February 2024 – DanCann Pharma A/S (SS: DANCAN) ("DanCann Pharma" or the "Company"), a Danish company powered by can...

Cision • 28 Feb 10:30

DanCann Pharma A/S Reports Fourth Quarter and Full Year 2023 Results

COPENHAGEN, Denmark, 28 February 2024 - DanCann Pharma A/S (SS: DANCAN) ("DanCann Pharma" or the "Company"), a Danish company powered by can...

Cision • 28 Feb 08:30

DanCann Pharma A/S Completes Issuance (8) of New Shares from Debt Conversion under the 10-Year Financing Loan-Agreement with 12-months Conversion Option with Nordic Growth Opportunities 2

COPENHAGEN, Denmark, 10 January 2024 – DanCann Pharma A/S (SS: DANCAN) ("DanCann Pharma" or the "Company"), a Danish company powered by cann...

Cision • 10 Jan 22:30

DanCann Pharma A/S delivers annual shareholder letter and investor update

COPENHAGEN, Denmark, 20 December 2023 - DanCann Pharma A/S (SS: DANCAN) ("DanCann Pharma" or the "Company"), a Danish company powered by can...

Cision • 20 Dec 2023 09:00

DanCann Pharma A/S: Flagging announcement

COPENHAGEN, Denmark, 30 November 2023, DanCann Pharma A/S ("DanCann" or the "Company"), a Danish company powered by cannabinoids, hereby ann...

Cision • 30 Nov 2023 18:10

DanCann Pharma A/S publishes Q3-2023 report

 COPENHAGEN, Denmark, 30 November 2023 - DanCann Pharma A/S (SS: DANCAN) ("DanCann Pharma" or the "Company"), a Danish company powered by ca...

Cision • 30 Nov 2023 18:00

DanCann Pharma A/S Completes Issuance (7) of New Shares under the Loan-Agreement with Nordic Growth Opportunities 2 - Marking a Milestone with a Conversion Rate Exceeding 50 percent of Tranche 1

COPENHAGEN, Denmark, 28 November 2023 – DanCann Pharma A/S (SS: DANCAN) (OTCQB: DCPXF) ("DanCann Pharma" or the "Company"), a Danish company...

Cision • 28 Nov 2023 22:00

DanCann Pharma A/S Completes Issuance (6) of New Shares from Debt Conversion under the 10-Year Financing Loan-Agreement with 12-months Conversion Option with Nordic Growth Opportunities 2

COPENHAGEN, Denmark, 22 November 2023 – DanCann Pharma A/S (SS: DANCAN) ("DanCann Pharma" or the "Company"), a Danish company powered by can...

Cision • 22 Nov 2023 21:30

DanCann Pharma A/S: Future strategic direction

COPENHAGEN, Denmark, 26 October 2023 – DanCann Pharma A/S (SS: DANCAN) (OTCQB: DCPXF) ("DanCann Pharma" or the "Company"), a Danish company ...

Cision • 26 Oct 2023 17:30

DanCann Pharma A/S Completes Issuance (5) of New Shares from Debt Conversion under the 10-Year Financing Loan-Agreement with 12-months Conversion Option with Nordic Growth Opportunities 2

COPENHAGEN, Denmark, 04 October 2023 – DanCann Pharma A/S (SS: DANCAN) (OTCQB: DCPXF) ("DanCann Pharma" or the "Company"), a Danish company ...

Cision • 04 Oct 2023 08:00

DanCann Pharma A/S aims to accelerate business and revenue growth: Comprehensive strategy update to follow in October

COPENHAGEN, Denmark, 02 October 2023 – DanCann Pharma A/S, DanCann Pharma A/S (SS: DANCAN) (OTCQB: DCPXF) ("DanCann Pharma" or the "Company"...

Cision • 02 Oct 2023 13:00

DanCann Pharma A/S Completes Issuance (4) of New Shares from Debt Conversion under the 10-Year Financing Loan-Agreement with 12-months Conversion Option with Nordic Growth Opportunities 2

COPENHAGEN, Denmark, 26 September 2023 – DanCann Pharma A/S (SS: DANCAN) (OTCQB: DCPXF) ("DanCann Pharma" or the "Company"), a Danish compan...

Cision • 26 Sep 2023 08:45

DanCann Pharma A/S Completes Issuance (3) of New Shares from Debt Conversion under the 10-Year Financing Loan-Agreement with 12-months Conversion Option with Nordic Growth Opportunities 2

COPENHAGEN, Denmark, 31 August 2023 – DanCann Pharma A/S (SS: DANCAN) (OTCQB: DCPXF) ("DanCann Pharma" or the "Company"), a Danish company p...

Cision • 31 Aug 2023 21:00

DanCann Pharma A/S publishes Q2-2023 report

COPENHAGEN, Denmark, 31 August 2023 - DanCann Pharma A/S (SS: DANCAN) (OTCQB: DCPXF) ("DanCann Pharma" or the "Company"), a Danish company p...

Cision • 31 Aug 2023 17:30

DanCann Pharma A/S to refocus its strategy - will reinvigorate its pipeline and product portfolio, and start looking for future owner or partnership for BP1

COPENHAGEN, Denmark, 31 August 2023 – DanCann Pharma A/S (SS: DANCAN) (OTCQB: DCPXF) ("DanCann Pharma" or the "Company"), a Danish company p...

Cision • 31 Aug 2023 08:30

Correction: DanCann Pharma A/S Completes Issuance (2) of New Shares from Debt Conversion under the 10-Year Financing Loan-Agreement with 12-months Conversion Option with Nordic Growth Opportunities 2

Correction of earlier press release published today: In the earlier press release issued today, the following statement was provided: "As a ...

Cision • 18 Aug 2023 20:00

DanCann Pharma A/S Completes Issuance (2) of New Shares from Debt Conversion under the 10-Year Financing Loan-Agreement with 12-months Conversion Option with Nordic Growth Opportunities 2

COPENHAGEN, Denmark, 18 August 2023 – DanCann Pharma A/S (SS: DANCAN) (OTCQB: DCPXF) ("DanCann Pharma" or the "Company"), a Danish company p...

Cision • 18 Aug 2023 18:00

DanCann Pharma A/S Completes Issuance of New Shares from Debt Conversion under the 10-Year Financing Loan-Agreement with 12-months Conversion Option with Nordic Growth Opportunities 2

COPENHAGEN, Denmark, 27 July 2023 – DanCann Pharma A/S (SS: DANCAN) (OTCQB: DCPXF) ("DanCann Pharma" or the "Company"), a Danish company pow...

Cision • 27 Jul 2023 23:00

DanCann Pharma A/S Successfully Receives First Tranche from the 10-Year Financing Loan-Agreement with 12-months Conversion Option and Warrants with Nordic Growth Opportunities 2

COPENHAGEN, Denmark, 17 July 2023 - DanCann Pharma A/S (SS: DANCAN) (OTCQB: DCPXF) ("DanCann Pharma" or the "Company"), a Danish company pow...

Cision • 17 Jul 2023 18:00

DanCann Pharma A/S: MINUTES OF EXTRAORDINARY GENERAL MEETING

DanCann Pharma A/S: MINUTES OF EXTRAORDINARY GENERAL MEETING

Cision • 20 Jun 2023 12:50

DanCann Pharma A/S: NOTICE OF EXTRAORDINARY GENERAL MEETING IN DANCANN PHARMA A/S

DanCann Pharma A/S: NOTICE OF EXTRAORDINARY GENERAL MEETING IN DANCANN PHARMA A/S

Cision • 02 Jun 2023 18:00

DanCann Pharma A/S Secures 10-Year Financing Loan-Agreement with 12-months Conversion Option and Warrants

COPENHAGEN, Denmark, 02 June 2023 - DanCann Pharma A/S (SS: DANCAN) (OTCQB: DCPXF) ("DanCann Pharma" or the "Company"), a Danish company pow...

Cision • 02 Jun 2023 17:20

DanCann Pharma receives approximately DKK 5.6 million from the exercise of series TO 2 together with a directed issue to the underwriters

COPENHAGEN, Denmark, 02 June 2023 - DanCann Pharma A/S (SS: DANCAN) ("DanCann Pharma" or the "Company"), a Danish company powered by cannabi...

Cision • 02 Jun 2023 17:15

DanCann Pharma A/S' Pre-Validation Batches Meets European Standards, paving the Path for Final Product Approval

COPENHAGEN, Denmark, 01 June 2023 - DanCann Pharma A/S (SS: DANCAN) (OTCQB: DCPXF) ("DanCann Pharma" or the "Company"), a Danish biopharmace...

Cision • 01 Jun 2023 09:00

DanCann Pharma A/S publishes Q1-2023 report

COPENHAGEN, Denmark, 31 May 2023 - DanCann Pharma A/S (SS: DANCAN) (OTCQB: DCPXF) ("DanCann Pharma" or the "Company"), a Danish company powe...

Cision • 31 May 2023 18:00

DanCann Pharma A/S: MINUTES OF ANNUAL GENERAL MEETING

DanCann Pharma A/S: MINUTES OF ANNUAL GENERAL MEETING

Cision • 30 May 2023 12:00

DanCann Pharma A/S has secured 71 percent of the TO 2’s

COPENHAGEN, Denmark, 26 May 2023 - DanCann Pharma A/S (SS: DANCAN) (OTCQB: DCPXF) ("DanCann Pharma" or the "Company"), a Danish company powe...

Cision • 26 May 2023 08:30

DanCann Pharma A/S has successfully completed pre-validation batches and expects final approval from the Danish Medicines Agency by the end of summer

COPENHAGEN, Denmark, 26 May 2023 - DanCann Pharma A/S (SS: DANCAN) (OTCQB: DCPXF) ("DanCann Pharma" or the "Company"), a Danish company powe...

Cision • 26 May 2023 08:15

DanCann Pharma A/S in advanced talks with new investor of additional DKK 12 million for topping up the outcome of the TO 2’s

COPENHAGEN, Denmark, 26 May 2023 - DanCann Pharma A/S (SS: DANCAN) (OTCQB: DCPXF) ("DanCann Pharma" or the "Company"), a Danish company powe...

Cision • 26 May 2023 08:00

Correction: DanCann Pharma A/S invites to an investor presentation and Q&A session in relation to ongoing exercise period of warrants

Correction of earlier press release published today: The previous press release stated that the investor presentation took place on May 4, w...

Cision • 24 May 2023 09:42

DanCann Pharma A/S invites to an investor presentation and Q&A session in relation to ongoing exercise period of warrants

COPENHAGEN, Denmark, 24 May 2023 - DanCann Pharma A/S (SS: DANCAN) ("DanCann Pharma" or the "Company"), a Danish company powered by cannabin...

Cision • 24 May 2023 09:00

DanCann Pharma A/S: The exercise period for warrants of series TO 2 begins today

COPENHAGEN, Denmark, 16 May 2023 - DanCann Pharma A/S (SS: DANCAN) ("DanCann Pharma" or the "Company"), a Danish company powered by cannabin...

Cision • 16 May 2023 09:00

DanCann Pharma A/S: The subscription price for warrants of series TO 2 has been set

COPENHAGEN, Denmark, 15 May 2023 - DanCann Pharma A/S (SS: DANCAN) ("DanCann Pharma" or the "Company"), a Danish company powered by cannabin...

Cision • 15 May 2023 17:00

DanCann Pharma A/S is strengthening its regulatory focus by appointing a life science lawyer to the board of directors

Copenhagen, Denmark, May 12, 2023 - DanCann Pharma A/S (SS: DANCAN) (OTCQB: DCPXF) ("DanCann Pharma" or "the Company"), a Danish company pow...

Cision • 12 May 2023 09:05

NOTICE OF ANNUAL GENERAL MEETING 2023 IN DANCANN PHARMA A/S

NOTICE OF ANNUAL GENERAL MEETING 2023 IN DANCANN PHARMA A/S

Cision • 12 May 2023 08:50

DanCann Pharma A/S publishes Annual Report 2022

COPENHAGEN, Denmark, 12 May 2023 - DanCann Pharma A/S (SS: DANCAN) (OTCQB: DCPXF) ("DanCann Pharma" or the "Company"), a Danish company powe...

Cision • 12 May 2023 08:45

DanCann Pharma A/S has signed an exclusive contract with MYCB1 GmbH for the distribution of full-spectrum extracts based on Bedrocan International varieties

DanCann Pharma A/S (SS: DANCAN) (OTCQB: DCPXF) ("DanCann Pharma" or the "Company"), a Danish company powered by cannabinoids, hereby announc...

Cision • 09 May 2023 09:00

Correction: DanCann Pharma A/S is reducing its debt with current lenders through a share issue by conversion of debt at market conditions

Correction of press release of 21 March 2023: In the original press release, it was stated that DanCann Pharma A/S has issued 2,031,250 shar...

Cision • 20 Apr 2023 20:00

DanCann Pharma A/S presented their work to the Ministry of Foreign Affairs

COPENHAGEN, Denmark, April 03, 2023 - DanCann Pharma A/S (SS: DANCAN) (OTCQB: DCPXF) ("DanCann Pharma" or "the Company"), a Danish company p...

Cision • 03 Apr 2023 08:00

DanCann Pharma A/S is reducing its debt with current lenders through a directed share issue at market conditions

COPENHAGEN, Denmark, 21 March 2023 - DanCann Pharma A/S (SS: DANCAN) (OTCQB: DCPXF) ("DanCann Pharma" or the "Company"), a Danish company po...

Cision • 21 Mar 2023 08:00

DanCann Pharma A/S Provides Positive Insight on Progress of Cannabis Bulk Product Approval

COPENHAGEN, Denmark, 14 March 2023 - DanCann Pharma A/S (SS: DANCAN) (OTCQB: DCPXF) ("DanCann Pharma" or the "Company"), a Danish company po...

Cision • 14 Mar 2023 08:30

DanCann Pharma A/S publishes Q4-2022 report

COPENHAGEN, Denmark, 28 February 2023 - DanCann Pharma A/S (SS: DANCAN) (OTCQB: DCPXF) ("DanCann Pharma" or the "Company"), a Danish company...

Cision • 28 Feb 2023 08:00

DanCann Pharma A/S: The first repackaging process has been completed at the new CannGros ApS facilities in Ansager

COPENHAGEN, Denmark, 24 February 2023 - DanCann Pharma A/S (SS: DANCAN) (OTCQB: DCPXF) ("DanCann Pharma" or the "Company"), a Danish company...

Cision • 24 Feb 2023 13:00

DanCann Pharma A/S and CannGros ApS open office in Odense

COPENHAGEN, Denmark, 23 February 2023 - DanCann Pharma A/S (SS: DANCAN) (OTCQB: DCPXF) ("DanCann Pharma" or the "Company"), a Danish company...

Cision • 23 Feb 2023 13:00

DanCann Pharma A/S has appointed Peter Søndergaard as new fulltime CFO

COPENHAGEN, Denmark, 4 January 2023 - DanCann Pharma A/S (SS: DANCAN) ("DanCann Pharma" or the "Company"), a Danish company powered by canna...

Cision • 04 Jan 2023 09:00

DanCann Pharma A/S strengthening the organization with new Head of Regulatory Affairs

COPENHAGEN, Denmark, 21 December 2022 - DanCann Pharma A/S (SS: DANCAN) DanCann Pharma A/S (“DanCann Pharma” or “DanCann Pharma Group”) here...

Cision • 21 Dec 2022 09:00

DanCann Pharma A/S: A strengthened market position after an impressive H2-2022

COPENHAGEN, Denmark, 14 December 2022 - DanCann Pharma A/S (SS: DANCAN) ("DanCann Pharma" or the "Company"), a Danish company powered by can...

Cision • 14 Dec 2022 09:00

DanCann Pharma A/S: CannGros ApS’ new facilities in Ansager have been approved by the Danish Medicines Agency for import, repackaging and distribution

COPENHAGEN, Denmark, 13 December 2022 - DanCann Pharma A/S (SS: DANCAN) ("DanCann Pharma" or the "Company"), a Danish company powered by can...

Cision • 13 Dec 2022 09:00

DanCann Pharma A/S: The US will enable more research into medical cannabis

COPENHAGEN, Denmark, 12 December 2022 - DanCann Pharma A/S (SS: DANCAN) ("DanCann Pharma" or the "Company"), a Danish company powered by can...

Cision • 12 Dec 2022 09:00

DanCann Pharma A/S’ shares commence trading on the OTCQB venture market in the United States

COPENHAGEN, Denmark, 5 December 2022 - DanCann Pharma A/S (SS: DANCAN) ("DanCann Pharma" or the "Company"), a Danish company powered by cann...

Cision • 05 Dec 2022 08:00

DanCann Pharma A/S receives EU-GMP certification for its manufacturing facility Biotech Pharm1

COPENHAGEN, Denmark, 2 December 2022 - DanCann Pharma A/S (SS: DANCAN) ("DanCann Pharma" or the "Company"), a Danish company powered by cann...

Cision • 02 Dec 2022 08:00

DanCann Pharma A/S announces last day for trading in BTU and the first day of trading in the warrants of series TO 2

NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, HONG KONG, JAPAN, CANADA, RUS...

Cision • 30 Nov 2022 15:50

DanCann Pharma A/S announces outcome of the Rights Issue

NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, HONG KONG, JAPAN, CANADA, RUS...

Cision • 17 Nov 2022 17:30

DanCann Pharma A/S: A strong and growing organization is ready to fulfill the commercial ambitions

COPENHAGEN, Denmark, November 10, 2022 - DanCann Pharma A/S (SS: DANCAN) ("DanCann Pharma" or the “Company”), a Danish company powered by ca...

Cision • 10 Nov 2022 12:00

Last day of subscription of units in DanCann Pharma A/S ongoing rights issue and guidance on how to subscribe

COPENHAGEN, Denmark, November 09, 2022 - DanCann Pharma A/S (SS: DANCAN) ("DanCann Pharma" or the “Company”), a Danish company powered by ca...

Cision • 09 Nov 2022 08:00

DanCann Pharma A/S with inspection by the Danish Medicine Agency during Q4-2022: expects to get EU-GMP approval before end-2022

COPENHAGEN, Denmark, November 8, 2022 - DanCann Pharma A/S (SS: DANCAN) ("DanCann Pharma" or the “Company”), a Danish company powered by can...

Cision • 08 Nov 2022 10:00

DanCann Pharma A/S’ Board of Directors and Management have subscribed for units in the ongoing Rights Issue

COPENHAGEN, Denmark, 07 November 2022 - DanCann Pharma A/S (SS: DANCAN) ("DanCann Pharma" or the “Company”), a Danish company powered by can...

Cision • 07 Nov 2022 15:25

BioStock Studio: DanCann Pharma about the road to commercial breakthrough

DanCann Pharma is active within a growing field of drug development – medical cannabis and therapeutic cannabinoids.

Cision • 07 Nov 2022 09:57

DanCann Pharma A/S publishes a supplement to the prospectus for the rights issue

COPENHAGEN, Denmark, November 4, 2022 - DanCann Pharma A/S (SS: DANCAN) ("DanCann Pharma" or the “Company”), a Danish company powered by can...

Cision • 04 Nov 2022 11:15

BioStock: DanCann Pharma rides the cannabis legalisation wave

We are seeing a shift in the political will to decriminalise cannabis, not least in the US and Germany, where significant steps in legislatu...

Cision • 04 Nov 2022 09:21

DanCann Pharma A/S publishes Q3-2022 report

COPENHAGEN, Denmark, 04 November 2022 - DanCann Pharma A/S (SS: DANCAN) ("DanCann Pharma" or the “Company”), a Danish company powered by can...

Cision • 04 Nov 2022 08:00

DanCann Pharma A/S signs binding agreement with Polish company Storkpharm worth more than DKK 40 million

COPENHAGEN, Denmark, November 3, 2022 - DanCann Pharma A/S (SS: DANCAN) ("DanCann Pharma" or the “Company”), a Danish company powered by can...

Cision • 03 Nov 2022 09:20

BioStock Investor Pitch: DanCann Pharma

Danish DanCann Pharma’s goal is to improve the lives of patients through medical cannabis and cannabinoids.

Cision • 02 Nov 2022 08:59

DanCann Pharma A/S targeting annual revenue of approx. DKK 60-100 million – and with several new partner agreements in the pipeline

COPENHAGEN, Denmark, November 1, 2022 - DanCann Pharma A/S (SS: DANCAN) ("DanCann Pharma" or the “Company”), a Danish company powered by can...

Cision • 01 Nov 2022 09:00

DanCann Pharma A/S: The subscription period in DanCann Pharma’s Rights Issue begins today

COPENHAGEN, Denmark, October 31, 2022 - DanCann Pharma A/S (SS: DANCAN) ("DanCann Pharma" or the “Company”), a Danish company powered by can...

Cision • 31 Oct 2022 08:45

BioStock: DanCann Pharma towards commercialisation with rights issue

For DanCann, the aim is clear – to give patients who lack treatment options a better life through medical cannabis and cannabinoids.

Cision • 31 Oct 2022 08:14

DanCann Pharma A/S: Exciting developments in Germany regarding legalization of cannabis

COPENHAGEN, Denmark, October 27, 2022 - DanCann Pharma A/S (SS: DANCAN) ("DanCann Pharma" or the “Company”), a Danish company powered by can...

Cision • 27 Oct 2022 13:00

DanCann Pharma A/S brings forward the release of the quarterly report for Q3 2022

COPENHAGEN, Denmark, October 24, 2022 - DanCann Pharma A/S (SS: DANCAN) ("DanCann Pharma" or the “Company”), a Danish company powered by can...

Cision • 24 Oct 2022 17:00

Board of Directors in DanCann Pharma A/S has resolved on a partially (77 percent) secured Rights Issue of approximately DKK 28.5 million and publishes prospectus

COPENHAGEN, Denmark, October 21, 2022 - DanCann Pharma A/S (SS: DANCAN) ("DanCann Pharma" or the “Company”), a Danish company powered by can...

Cision • 21 Oct 2022 11:30

DanCann Pharma A/S: Upcoming legalization in the US and Germany will have a major impact on the acceptance of cannabis worldwide

COPENHAGEN, Denmark, October 11, 2022 - DanCann Pharma A/S (SS: DANCAN) ("DanCann Pharma" or the “Company”), a Danish company powered by can...

Cision • 11 Oct 2022 09:00

DanCann Pharma A/S has appointed Alexander Schoeneck and Jeppe Krog Rasmussen to the Board of Directors

COPENHAGEN, Denmark, September 22, 2022 - DanCann Pharma A/S (SS: DANCAN) ("DanCann Pharma", “DCP” or the “Company”), a Danish company power...

Cision • 22 Sep 2022 13:00

DanCann Pharma A/S: Minutes of annual general meeting

held in Dancann Pharma A/S, business reg. no. 39 42 60 05 (“Company”)

Cision • 20 Sep 2022 15:10

DanCann Pharma A/S: Pain specialist Tina Horsted and DanCann Pharma A/S in collaboration on ambitious patient project

COPENHAGEN, Denmark, September 12, 2022 - DanCann Pharma A/S (SS: DANCAN) ("DanCann Pharma" or the “Company”), a Danish company powered by c...

Cision • 12 Sep 2022 10:00

DanCann Pharma A/S: Carsten Trads, Chairman, comments on the Rights Issue

COPENHAGEN, Denmark, September 5, 2022 - DanCann Pharma A/S (SS: DANCAN) ("DanCann Pharma", “DCP” or the “Company”), a Danish company powere...

Cision • 05 Sep 2022 13:55